GLP-1 Analogues Market Expected to Reach US$ 322.85 Billion by 2034 with a 21.3% CAGR
GLP-1 Analogues Market.
The blood sugar levels are controlled by improving insulin secretion driving the market demand.
Suppression of glucagon release and retarding gastric emptying lessens the blood glucose level and helps in weight management”
NEW YORK CITY, NY, UNITED STATES, November 12, 2024 /EINPresswire.com/ -- Our GLP-1 analogues market report has been prepared using advanced methodologies and research techniques to help businesses make strategic business decisions.— Polaris Market Research
𝐓𝐡𝐞 𝐦𝐨𝐬𝐭 𝐫𝐞𝐜𝐞𝐧𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐬𝐭𝐮𝐝𝐲 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐯𝐞𝐚𝐥𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐆𝐋𝐏-1 𝐚𝐧𝐚𝐥𝐨𝐠𝐮𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐟𝐥𝐨𝐮𝐫𝐢𝐬𝐡 𝐚𝐭 𝐚 𝐬𝐭𝐚𝐛𝐥𝐞 𝐫𝐚𝐭𝐞. 𝐖𝐢𝐭𝐡 𝐚 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐂𝐀𝐆𝐑 𝐨𝐟 21.3%, 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 46.70 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024. 𝐈𝐭 𝐢𝐬 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 322.85 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2034.
𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
GLP-1 analogues are a category of medicines that predominantly handle blood sugar levels in people with level 2 diabetes. A few GLP-1 analogues can cure obesity. GLP-1 analogues are the most frequently injectable medications, indicating one can inject a liquid medication with a needle and a syringe. One injects shots into fatty tissue just beneath the skin.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/glp-1-analogues-market/request-for-sample?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01
In GLP-1 analogues, analogues is an assembled commodity that connects to cell receptor and generates similar action as organically transpiring substance. GLP-1 medications secure GLP receptors to activate the impacts of the GLP-1 hormone. The clinical directives and advice from enhanced health establishments such as the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) continually validate the usage of GLP-1 analogues for particular patient relations pushing the GLP-1 analogues market demand.
𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐢𝐧 𝐆𝐋𝐏-1 𝐀𝐧𝐚𝐥𝐨𝐠𝐮𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭:
• AstraZeneca
• Bristol-Myers Squibb Company
• D&D Pharmatech
• Eccogen
• Eli Lilly and Company
• Glenmark Pharmaceuticals Ltd.
• Hanmi Pharm. Co., Ltd.
• Lexicon Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Novo Nordisk A/S
• Sanofi
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞: https://www.polarismarketresearch.com/industry-analysis/glp-1-analogues-market/request-for-discount-pricing?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01
𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:
Intake of Highly Processed Food: Intake of excessively processed foods and food components carrying refined sugars and detrimental fats is a notable presenting element causing the surging cases of type 2 diabetes boosting the demand for GLP-1 analogues market growth.
Rising Older Population: Elder persons, because of age-connected elements, are at a higher probability of advancing type 2 diabetes and connected health situations, causing a substantial requirement for GLP-1 analogues inhibitors.
Growing Existence of Type 2 Diabetes: As per the International Diabetes Federation, 537 million persons were impacted by diabetes globally in 2021, with a sizeable 75% of adult diabetes cases taking place in low and middle-income nations. The International Diabetes Federation proposed that the aggregate of contemporary diabetes cases is anticipated to reach 643 million by 2030 and 783 million by 2045.
𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
• The GLP-1 analogues market segmentation is based on route of administration, product, application, distribution channel and region.
• By product analysis, the ozempic segment held the largest market share. This is due to its virtue in regulating blood glucose levels in patients impacted by type 2 diabetes.
• By distribution channel analysis, the online pharmacies segment is poised to register a significant CAGR. This is due to the exceptional ease of permitting patients to order their medicines from the ease of their homes.
𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
The research report covers all the major regions and sub-regions of the GLP-1 analogues market. The study provides market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America: North America accounted for the largest market share. This is primarily because nations in North America, especially the US, have the biggest proportion of diabetes and obesity in the world.
Asia Pacific: Asia Pacific is anticipated to witness the fastest CAGR from 2024 to 2032. The region's growing percentage of the aging population fuels the regional market expansion.
𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞: https://www.polarismarketresearch.com/industry-analysis/glp-1-analogues-market/inquire-before-buying?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01
𝐅𝐀𝐐𝐬:
How much is the GLP-1 analogues market?
The market size was valued at USD 46.70 billion in 2024.
What is the growth rate of GLP-1 analogues market?
The global market is projected to register a CAGR of 21.3% during 2025–2034.
Which region held the largest market share?
North America accounted for the largest share of the global market.
Which product led the market in 2024?
The ozempic segment dominated the market in 2024.
𝐁𝐫𝐨𝐰𝐬𝐞 𝐏𝐌𝐑'𝐬 𝐆𝐋𝐏-1 𝐀𝐧𝐚𝐥𝐨𝐠𝐮𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐟𝐫𝐨𝐦 𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐏𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:
𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐆𝐋𝐏-1 𝐚𝐧𝐚𝐥𝐨𝐠𝐮𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 322.85 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2034, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 21.3% 𝐝𝐮𝐫𝐢𝐧𝐠 2025–2034.
𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Amyloidosis Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/amyloidosis-treatment-market
Europe SGLT2 Inhibitors Market:
https://www.polarismarketresearch.com/industry-analysis/europe-sglt2-inhibitors-market
Protein A, G and L Resins Market:
https://www.polarismarketresearch.com/industry-analysis/protein-a-g-and-l-resins-market
Natural Sulforaphane Market:
https://www.polarismarketresearch.com/industry-analysis/natural-sulforaphane-market
Clinical Nutrition for Cancer Care Market:
https://www.polarismarketresearch.com/industry-analysis/clinical-nutrition-for-cancer-care-market
𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
Likhil G
Polaris Market Research and Consulting
+ + +1 929-297-9727
sales@polarismarketresearch.com
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
